Here are the key facts of this story, as agreed upon by ¹Al Jazeera, ²Reuters, ³Times, ⁴Guardian, and ⁵Inews.co.uk. According to clinical trial data presented Sunday at an American Society of Clinical Oncology conference in Chicago, AstraZeneca’s lung cancer drug cut the risk of dying from a specific form of…